Clinical Trials on Immune Response of Host in Finland
Total 155 results
-
Helsinki University Central HospitalUnknownMeasurement of Immune Response to Prevenar13 | Measurement of Immune Response to Hepatitis AFinland, Sweden
-
Turku University HospitalMead Johnson Nutrition; Academy of FinlandCompletedGut Microbiota | Skin Microbiota | Humoral Immune Responses | Severity of Atopic DermatitisFinland
-
University of OuluOulu University Hospital; University of Eastern Finland; Verve Research, Oulu...UnknownCost-effectiveness of Exercise-based Rehabilitation ProgramFinland
-
Turku University HospitalEnrolling by invitationMultiple SclerosisFinland
-
Turku University HospitalActive, not recruitingMultiple SclerosisFinland
-
University of OuluBusiness FinlandCompletedQuality of Life | Physical Fitness | Autonomic Nervous System Imbalance | Patient AdherenceFinland
-
Turku University HospitalActive, not recruiting
-
Finnish Institute of Occupational HealthCity of Helsinki; Finnish Work Environment Fund; The Social Insurance Institution... and other collaboratorsCompletedEnvironmental Illness | Functional SymptomsFinland
-
Turku University HospitalEnrolling by invitationMultiple SclerosisFinland
-
Turku University HospitalRecruiting
-
Lars RomboCompletedResponse to Hepatitis A VaccineFinland, Sweden
-
Turku University HospitalCompletedMultiple SclerosisFinland
-
University of TurkuUnknownColecalciferol as an Add-on Treatment to Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)Multiple SclerosisFinland
-
Turku University HospitalActive, not recruitingMultiple SclerosisFinland
-
Helsinki University Central HospitalRecruitingPost Covid-19 ConditionFinland
-
BayerNovartis Pharmaceuticals; Biogen; EPID Research; Merck Serono Europe LtdCompleted
-
Turku University HospitalCompletedMultiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-RemittingFinland
-
University of Eastern FinlandCompletedQuality of Life | Fatigue | Physical Activity | Relapsing Remitting Multiple SclerosisFinland
-
BayerBiogen Netherlands B.V; Novartis Europharm Limited; Merck Europe B.V.Not yet recruitingMultiple Sclerosis (MS)Sweden, Finland
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States, Spain, Belgium, France, Italy, Korea, Republic of, Finland, United Kingdom, Germany, Israel, Switzerland, Austria, Australia, Czechia, Greece, New Zealand, Poland, Portugal, Taiwan
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisFinland
-
Riku Antero PalanneHelsinki University Central Hospital; University of Helsinki; FinlandCompletedRheumatoid Arthritis | Knee Osteoarthritis | Anesthesia | Knee Pain Chronic | Arthropathy of Knee JointFinland
-
Kuopio University HospitalCompletedRelapse-remitting Multiple SclerosisFinland
-
Finnish MS SocietySeinajoki Central Hospital; Social Insurance Institution, Finland; Tampere University...Completed
-
Brown UniversityRecruitingAlcohol Drinking | HIV ViremiaUnited States
-
BayerCompletedMultiple SclerosisGermany, Austria, United Kingdom, Israel, Belgium, Finland
-
Zimmer BiometRecruitingPost-traumatic Arthritis | Degenerative Arthritis | Elbow Joint Destruction | Post-traumatic Lesions | Ankylosed Joints | Advanced Rheumatoid Arthritis | Joint Instability or Loss of Motion | Acute Comminuted Articular Fracture of Elbow Joint Surfaces | Bone Loss Contributing to Elbow Instability | Bilateral...United States, Australia, Finland, France, Germany, Italy, Netherlands, United Kingdom
-
SanofiCompletedMultiple SclerosisUnited States, France, Canada, Germany, Spain, Finland, Norway
-
Incyte CorporationTerminatedChronic Graft-versus-host DiseaseUnited States, Spain, France, Canada, Israel, United Kingdom, Germany, Italy, Denmark, Sweden, Finland, Belgium, Poland, Greece, Austria, Switzerland
-
Zimmer BiometActive, not recruitingAvascular Necrosis | Inflammatory Arthritis | Osteoarthritis, Hip | Congenital Hip Dysplasia | Post-traumatic; Arthrosis | Rheumatoid Arthritis With Adequate Bone QualityNetherlands, Finland, Belgium, France, Spain, Australia, Canada, United Kingdom
-
Zimmer BiometActive, not recruitingRheumatoid Arthritis | Degenerative Arthritis | Post Traumatic ArthritisUnited States, Switzerland, Canada, Finland, Germany, Italy
-
US Department of Veterans AffairsTerminated
-
US Department of Veterans AffairsCompletedMultiple SclerosisUnited States
-
DePuy InternationalTerminatedOsteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Post-traumatic Arthritis | Congenital Hip Dysplasia | Slipped Capital Femoral Epiphysis | Collagen Disorders | Nonunion of Femoral FracturesAustria, Czech Republic, Finland, Germany, Norway, Portugal, Switzerland, United Kingdom
-
BayerCompletedMultiple SclerosisSwitzerland, Poland, France, Germany, Hungary, Spain, Sweden, Austria, Czech Republic, Italy, Slovenia, Israel, Belgium, Denmark, Netherlands, Canada, Norway, Finland
-
BiogenBiogen Idec A/SCompletedExerciseSweden, Finland, New Zealand, Denmark, Norway, Australia
-
US Department of Veterans AffairsTerminated
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphoma | Graft Versus Host DiseaseUnited States
-
Catalyst OrthoScienceRecruitingOsteoarthritis Shoulder | Avascular Necrosis of the Head of Humerus | Rheumatoid Arthritis ShoulderUnited States
-
BiogenCompletedRelapsing-remitting Multiple SclerosisBelgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
-
US Department of Veterans AffairsCompletedMS (Multiple Sclerosis)United States
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisBelgium, Bulgaria, Canada, Croatia, Czech Republic, Finland, Germany, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, Turkey, Ukraine, United Kingdom
-
Eli Lilly and CompanyBioMS Technology Corp.CompletedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Germany, Latvia, Netherlands, Spain, Sweden, United Kingdom
-
Southwest Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group BCompletedLymphoma | Psychosocial Effects of Cancer and Its TreatmentUnited States
-
Eli Lilly and CompanyBioMS Technology Corp.TerminatedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Latvia, Spain, Sweden, United Kingdom, Germany, Netherlands
-
NovartisCompletedMultiple SclerosisSwitzerland, Germany, Spain, Portugal, Canada, Denmark, Finland, France, Italy, Poland, United Kingdom
-
CSL BehringCompletedChronic Inflammatory Demyelinating PolyneuropathyPoland, France, Germany, Belgium, Finland
-
SanofiCompletedMultiple SclerosisUkraine, Russian Federation, Estonia, Czech Republic, Denmark, Finland, France, Turkey, United Kingdom, United States, Portugal, Austria, Canada, Chile, Germany, Italy, Netherlands, Norway, Poland, Sweden, Switzerland
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisCroatia, Bulgaria, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Poland, Belgium, Hungary, Serbia, Finland, Ukraine, Switzerland, Canada, Turkey
-
UCB PharmaBiogenTerminatedMultiple SclerosisUnited States, France, Germany, Spain, Canada, Netherlands, Belgium, Hungary, Sweden, United Kingdom, Finland